Additional studies are revealing other markers of RA, such as sNRP-1 [10], CELF-6 [10], COX-2 [11], and rgs-1 [12], with subsequent animal model studies suggesting that inhibiting the expression of these biomarker proteins could effectively alleviate inflammation and delay disease progression in RA [13]. This evidence concerns the gene CELF6 and rheumatoid arthritis.